−0.004AUD
−3.40 MAUD
15.37 KAUD
708.59 M
About MEMPHASYS LIMITED.
Sector
Industry
CEO
David Ali
Website
Headquarters
Sydney
Founded
2006
ISIN
AU000000MEM5
FIGI
BBG000QRTJ80
Memphasys Ltd. is a life sciences company, which engages in the development and commercialization of novel reproduction and fertility solutions for humans and animals. The company was founded in 2006 and is headquartered in Sydney, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MEM is 0.009 AUD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange MEMPHASYS LIMITED. stocks are traded under the ticker MEM.
MEM stock is 12.50% volatile and has beta coefficient of −1.02. Check out the list of the most volatile stocks — is MEMPHASYS LIMITED. there?
Yes, you can track MEMPHASYS LIMITED. financials in yearly and quarterly reports right on TradingView.
MEM stock has fallen by 10.00% compared to the previous week, the month change is a 18.18% fall, over the last year MEMPHASYS LIMITED. has showed a 47.81% decrease.
MEM net income for the last quarter is −2.30 M AUD, while the quarter before that showed −2.22 M AUD of net income which accounts for −3.76% change. Track more MEMPHASYS LIMITED. financial stats to get the full picture.
No, MEM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MEM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEMPHASYS LIMITED. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEMPHASYS LIMITED. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEMPHASYS LIMITED. stock shows the sell signal. See more of MEMPHASYS LIMITED. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEMPHASYS LIMITED. EBITDA is −3.99 M AUD, and current EBITDA margin is −19.65 K%. See more stats in MEMPHASYS LIMITED. financial statements.